BAJAJHCAREBajaj Healthcare Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹386.55
▲ 3.37%Average
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,301.20
P/E57.44
P/B2.31
PEG—
ROE %4.27
ROCE %9.90
Debt / Equity0.47
EPS6.73
Revenue Growth %-0.90
Profit Growth %-60.10
Dividend Yield %0.26
Promoter Holding %64.03
FII Holding %1.91
DII Holding %—
Beta0.18
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Double Bottom | LONG | 67% | ₹386.55 | ₹327.60 | ₹445.30 | 1.00 |
HOLDConviction 58%
The picture
- • Debt/Equity: 0.47
- • Promoter holding: 64.0%
- • RSI: 74
- • MACD: bullish
- • Price vs EMA21: above
- • 1-month return: +23.5%
- • Double Bottom signal (setup quality 67%)
Bull case
- • Debt/Equity: 0.47
- • Promoter holding: 64.0%
- • RSI: 74
- • MACD: bullish
Bear case
- • Revenue growth: -0.9% YoY
- • Profit growth: -60.1% YoY
- • Golden cross setup: SMA50 below SMA200
- • Volume: 0.9x 20-day average
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: -0.9% YoY
- • Profit growth: -60.1% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹386.55
Stop Loss
₹347.82
risk 10%
Target 1 (1.5R)
₹444.64
+15.0%
Target 2 (3R)
₹502.74
+30.1%
Support (20d)
₹301.10
Resistance (52w)
₹543.22
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹38.73/share
ATR (volatility)
₹15.49
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹15.49). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
31
Technical
70
Momentum
68
Risk (safety)
43